Journal
BIOTECHNOLOGY LETTERS
Volume 32, Issue 10, Pages 1373-1383Publisher
SPRINGER
DOI: 10.1007/s10529-010-0326-5
Keywords
Chlamydomonas; Micro-algae; Recombinant protein expression; Therapeutic protein production
Categories
Funding
- National Institute of Allergy and Infectious Diseases [AI059614]
- National Science Foundation
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059614] Funding Source: NIH RePORTER
Ask authors/readers for more resources
A complete set of genetic tools is still being developed for the micro-alga Chlamydomonas reinhardtii. Yet even with this incomplete set, this photosynthetic single-celled plant has demonstrated significant promise as a platform for recombinant protein expression. In recent years, techniques have been developed that allow for robust expression of genes from both the nuclear and plastid genome. With these advances, many research groups have examined the pliability of this and other micro-algae as biological machines capable of producing recombinant peptides and proteins. This review describes recent successes in recombinant protein production in Chlamydomonas, including production of complex mammalian therapeutic proteins and monoclonal antibodies at levels sufficient for production at economic parity with existing production platforms. These advances have also shed light on the details of algal protein production at the molecular level, and provide insight into the next steps for optimizing micro-algae as a useful platform for the production of therapeutic and industrially relevant recombinant proteins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available